Annals of Oncology Advance Access originally published online on April 25, 2005
Annals of Oncology 2005 16(6):928-933; doi:10.1093/annonc/mdi182
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2005 European Society for Medical Oncology
Akt activation in renal cell carcinoma: contribution of a decreased PTEN expression and the induction of apoptosis by an Akt inhibitor
Department of Urology, Keio University School of Medicine, Tokyo, Japan
* Correspondence to: Dr M. Oya, Department of Urology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan. Tel: +81-3-5363-3825; Fax: +81-3-3225-1985; Email: moto-oya{at}sc.itc.keio.ac.jp
Background:: Akt has been implicated in the oncogenesis of human malignant tumors, because Akt regulates many key effector molecules involved in cell survival. PTEN (phosphatase and tensin homolog deleted on chromosome 10) negatively regulates Akt activation.
Materials and methods:: The expression of phosphorylated Akt (p-Akt), total Akt and PTEN was analyzed by Western blotting in 45 renal cell carcinoma (RCC) patients. The Bad and phosphorylated Bad (p-Bad) statuses were analyzed in 20 RCC patients. A phosphatidylinositol ether analog was used as an Akt inhibitor to treat four RCC cell lines, namely Caki-1, KU19-20, SW839 and Caki-2.
Results:: The PTEN expression in RCC was observed to decrease and p-Akt expression to increase significantly in comparison with that in the corresponding normal kidney tissue. The PTEN expression inversely correlated with the p-Akt expression. These alterations were specific for clear cell type RCC, but not for papillary or chromophobe type RCC. Alterations in Bad phosphorylation were also specifically observed in clear cell type. The Akt inhibitor induced apoptosis in KU19-20 and Caki-2 cells with a high Akt activity.
Conclusions:: A decreased expression of PTEN may be an underlying mechanism for Akt activation. An Akt inhibitor may be a therapeutic option for a subset of RCC with an elevated Akt activity.
Key words: Akt, Bad, PTEN, renal cell carcinoma
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  H.-J. Choi, T.-W. Chung, S.-J. Kim, S.-Y. Cho, Y.-S. Lee, Y.-C. Lee, J.-H. Ko, and C.-H. Kim The AP-2{alpha} transcription factor is required for the ganglioside GM3-stimulated transcriptional regulation of a PTEN gene Glycobiology, May 1, 2008; 18(5): 395 - 407. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-I Chao, W.-C. Su, and H.-F. Liu Baicalein induces cancer cell death and proliferation retardation by the inhibition of CDC2 kinase and survivin associated with opposite role of p38 mitogen-activated protein kinase and AKT Mol. Cancer Ther., November 1, 2007; 6(11): 3039 - 3048. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Cho, S. Signoretti, M. Regan, J. W. Mier, and M. B. Atkins The Role of Mammalian Target of Rapamycin Inhibitors in the Treatment of Advanced Renal Cancer Clin. Cancer Res., January 15, 2007; 13(2): 758s - 763s. [Abstract] [Full Text] [PDF]
|
|